-

LAWSUIT ALERT: Investors Who Lost Over $100,000 With ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Shares - Purchased Between March and June 2026 - Should Contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announces that a deadline is coming up on October 05, 2026, in the lawsuit that was filed for certain investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) in the U.S. District Court for Southern District of California (No: 3:26-cv-04469).

NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Share

Investors, who purchased shares in excess of $100,000 of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, have certain options and there are short and strict deadlines running. Deadline: October 5, 2026. Those NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 05, 2024, a NASDAQ: SPRY investor filed lawsuit against ARS Pharmaceuticals, Inc. The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the defendants knew or recklessly disregarded potential timeline issues with CVS Caremark’s formulary addition and coverage decision related to neffy, that the guidance ARS Pharmaceuticals provided to investors related to the timeline for expansion of insurance coverage for neffy with CVS Caremark may be significantly shifted, impacting commercialization efforts; and that the expanded insurance coverage may not be available by the July 1 deadline, thus, ARS Pharmaceuticals would not have the expanded insurance coverage for neffy with CVS Caremark for the summer and back-to-school seasons.

Those who purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

Shareholders Foundation, Inc.

NASDAQ:SPRY
Details

Release Versions

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

More News From Shareholders Foundation, Inc.

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares in the U.S. District Court for the Northern District of California (No: 5:26-cv-07691). Investors, who purchased shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) have certain options. NASDAQ: PRCT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On...

LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares in the U.S. District Court for Southern District of California (No: 3:26-cv-04385). Investors, who purchased a significant amount of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline: Sep...

Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares in the U.S. District Court for the Southern District of California (No: 3:26-cv-04643). Investors, who purchased a significant amount of Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 13, 2025 and May 14, 2026, in excess of $100,000 have certain options and there are short and strict deadlines running. Deadline:...
Back to Newsroom